134 related articles for article (PubMed ID: 12732846)
1. Polymorphisms in the CYP1A2 gene and theophylline metabolism in patients with asthma.
Obase Y; Shimoda T; Kawano T; Saeki S; Tomari SY; Mitsuta-Izaki K; Matsuse H; Kinoshita M; Kohno S
Clin Pharmacol Ther; 2003 May; 73(5):468-74. PubMed ID: 12732846
[TBL] [Abstract][Full Text] [Related]
2. Associations between CYP2E1 promoter polymorphisms and plasma 1,3-dimethyluric acid/theophylline ratios.
Yoon Y; Park HD; Park KU; Kim JQ; Chang YS; Song J
Eur J Clin Pharmacol; 2006 Aug; 62(8):627-31. PubMed ID: 16841220
[TBL] [Abstract][Full Text] [Related]
3. Phenotype-genotype analysis of CYP1A2 in Japanese patients receiving oral theophylline therapy.
Takata K; Saruwatari J; Nakada N; Nakagawa M; Fukuda K; Tanaka F; Takenaka S; Mihara S; Marubayashi T; Nakagawa K
Eur J Clin Pharmacol; 2006 Jan; 62(1):23-8. PubMed ID: 16385402
[TBL] [Abstract][Full Text] [Related]
4. Lack of impact of CYP1A2 genetic polymorphism (C/A polymorphism at position 734 in intron 1 and G/A polymorphism at position -2964 in the 5'-flanking region of CYP1A2) on the plasma concentration of haloperidol in smoking male Japanese with schizophrenia.
Shimoda K; Someya T; Morita S; Hirokane G; Yokono A; Takahashi S; Okawa M
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):261-5. PubMed ID: 11817502
[TBL] [Abstract][Full Text] [Related]
5. Development of a high throughput single nucleotide polymorphism screening method for the cytochrome P450 1A2 polymorphisms CYP1A2*1C and CYP1A2*1F: are they useful as predictive markers in mental disorders?
Klemm M; Eidens M; Lorenz M; Prause S; Weise A; Dahmen N; Forst T; Pfützner A
Clin Lab; 2010; 56(9-10):473-80. PubMed ID: 21086794
[TBL] [Abstract][Full Text] [Related]
6. Genetic association analysis of functional polymorphisms in the cytochrome P450 1A2 (CYP1A2) gene with tardive dyskinesia in Japanese patients with schizophrenia.
Matsumoto C; Ohmori O; Shinkai T; Hori H; Nakamura J
Psychiatr Genet; 2004 Dec; 14(4):209-13. PubMed ID: 15564895
[TBL] [Abstract][Full Text] [Related]
7. Frequencies of four genetic polymorphisms in the CYP1A2 gene in Turkish population.
Bilgen T; Tosun O; Luleci G; Keser I
Genetika; 2008 Aug; 44(8):1133-6. PubMed ID: 18825963
[TBL] [Abstract][Full Text] [Related]
8. The effect of CYP1A2 gene polymorphisms on Theophylline metabolism and chronic obstructive pulmonary disease in Turkish patients.
Uslu A; Ogus C; Ozdemir T; Bilgen T; Tosun O; Keser I
BMB Rep; 2010 Aug; 43(8):530-4. PubMed ID: 20797314
[TBL] [Abstract][Full Text] [Related]
9. Detection of three genetic polymorphisms in the 5'-flanking region and intron 1 of human CYP1A2 in the Japanese population.
Chida M; Yokoi T; Fukui T; Kinoshita M; Yokota J; Kamataki T
Jpn J Cancer Res; 1999 Sep; 90(9):899-902. PubMed ID: 10551315
[TBL] [Abstract][Full Text] [Related]
10. Association between common CYP1A2 polymorphisms and theophylline metabolism in non-smoking healthy volunteers.
Wang L; Hu Z; Deng X; Wang Y; Zhang Z; Cheng ZN
Basic Clin Pharmacol Toxicol; 2013 Apr; 112(4):257-63. PubMed ID: 23167834
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of theophylline in adult Chinese patients with asthma and chronic obstructive pulmonary disease.
Ma Y; Xue L; Chen X; Kang Y; Wang Y; Wang L
Int J Clin Pharm; 2018 Oct; 40(5):1010-1018. PubMed ID: 29777329
[TBL] [Abstract][Full Text] [Related]
12. CYP1A2 polymorphism and theophylline clearance in Korean non-smoking asthmatics.
Yim EY; Kang HR; Jung JW; Sohn SW; Cho SH
Asia Pac Allergy; 2013 Oct; 3(4):231-40. PubMed ID: 24260728
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphism in the 5'-flanking region of human CYP1A2 gene: effect on the CYP1A2 inducibility in humans.
Nakajima M; Yokoi T; Mizutani M; Kinoshita M; Funayama M; Kamataki T
J Biochem; 1999 Apr; 125(4):803-8. PubMed ID: 10101295
[TBL] [Abstract][Full Text] [Related]
14. Analysis of single nucleotide polymorphisms in the 5'-flanking region of tumor necrosis factor-alpha gene in Japanese patients with early-onset periodontitis.
Endo M; Tai H; Tabeta K; Kobayashi T; Yamazaki K; Yoshie H
J Periodontol; 2001 Nov; 72(11):1554-9. PubMed ID: 11759867
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism.
Sachse C; Bhambra U; Smith G; Lightfoot TJ; Barrett JH; Scollay J; Garner RC; Boobis AR; Wolf CR; Gooderham NJ;
Br J Clin Pharmacol; 2003 Jan; 55(1):68-76. PubMed ID: 12534642
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1.
Aklillu E; Carrillo JA; Makonnen E; Hellman K; Pitarque M; Bertilsson L; Ingelman-Sundberg M
Mol Pharmacol; 2003 Sep; 64(3):659-69. PubMed ID: 12920202
[TBL] [Abstract][Full Text] [Related]
17. The G-113A polymorphism in CYP1A2 affects the caffeine metabolic ratio in a Chinese population.
Chen X; Wang L; Zhi L; Zhou G; Wang H; Zhang X; Hao B; Zhu Y; Cheng Z; He F
Clin Pharmacol Ther; 2005 Sep; 78(3):249-59. PubMed ID: 16153396
[TBL] [Abstract][Full Text] [Related]
18. Genotype and allele frequencies of polymorphic cytochromes P450 CYP1A2 and CYP2E1 in Mexicans.
Mendoza-Cantú A; Castorena-Torres F; Bermudez M; Martínez-Hernández R; Ortega A; Salinas JE; Albores A
Cell Biochem Funct; 2004; 22(1):29-34. PubMed ID: 14695651
[TBL] [Abstract][Full Text] [Related]
19. Rapid genotyping for relevant CYP1A2 alleles by pyrosequencing.
Skarke C; Kirchhof A; Geisslinger G; Lötsch J
Eur J Clin Pharmacol; 2005 Dec; 61(12):887-92. PubMed ID: 16307269
[TBL] [Abstract][Full Text] [Related]
20. Liver dysfunction markedly decreases the inhibition of cytochrome P450 1A2-mediated theophylline metabolism by fluvoxamine.
Orlando R; Padrini R; Perazzi M; De Martin S; Piccoli P; Palatini P
Clin Pharmacol Ther; 2006 May; 79(5):489-99. PubMed ID: 16678550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
